Home Search
"life science" - search results
If you're not happy with the results, please do another search
German TVM leads Europe’s largest second round life science investment this year
Ardana Bioscience, the speciality pharmaceutical company focused on reproductive health, has raised £20m second round funding. The deal represents the largest Series B life science funding round in Europe so far in 2003 and appears to signal a creeping upturn in the European life sciences sector.
US MPM Capital hires Dr. Bernice Welles as venture partner
MPM Capital, the US-based life sciences investor, has recruited Dr. Bernice Welles as venture partner in the firm's MPM BioVentures group. Welles will focus on evaluating potential investments with an emphasis on product candidates in discovery and development as well as working closely with MPM portfolio companies to build their pipelines.
Global Life Science Ventures leads E30m investment in Austrian biotech firm
Europe-based Global Life Science Ventures has led the E30m financing of Intercell, an Austrian biotech firm developing therapies and vaccines against infectious diseases.
First half European venture investment drops 55 per cent on year
European venture capital investment continued its downward slide in the first half of this year despite signs that technology public markets are staging a gentle recovery. The first six months saw E1.6bn invested in European companies, compared with E3.6bn in the same period of 2002, according to venture research firm Windmill.
Raising money in a difficult environment
Venture capital financing in the US life sciences market has plummeted year-on-year since the industry's peak in 2000. With increasingly fierce competition for venture funding Lawrence Wittenberg of Testa Hurwitz & Thibeault provides a step-by-step analysis of what a venture capital firm should be looking for in a biotech start-up.
People: June 2003
EVCA announces new chairman, Cees van Lede joins Carlyle, ComVentures loses David Helfrich and Aurora Funds recruits three new professionals…
North America: June 2003
CalSTRS seeks emerging managers, Stanford to increase private equity exposure, US valuations fall further, Florida drops plans to protect terms and conditions from public disclosure…
Funds: June 2003
Schroder Ventures raises $402m for third life sciences fund, Altor raises E650m for debut fund, 3i reaches E2.1bn first close for latest fund, ComVentures launches new fund, Swander Pace launches consumer products fund, GTCR Golder Rauner holds first close, Arsenal Capital Partners exceed target, Thayer closes below target…
Germany as a technology powerhouse
Germany's economy is characterised by technological leadership and a tradition of entrepreneurship, according to Wellington Partners. But investment in Germany's technology sector is hampered by an international perception of the country's sluggish economic growth and political gridlock.
Western Europe & Israel: June 2003
Deutsche Bank to sell $550m of collateralized fund obligations, Schroder Ventures closes $400m life sciences fund, UK private equity firms lose faith in non-executive directors and ABN Amro forms new private equity subsidiary…